In a decision with broad implications within and, potentially, outside the pharmaceutical industry, the Supreme Court has affirmed, by a 5-4 margin, the Ninth Circuit’s decision finding GlaxoSmithKline’s pharmaceutical sales representatives qualify for the outside sales exemption under the FLSA. Christopher v. SmithKline Beecham Corp., No. 11–204 (June 18, 2012). Justice Alito delivered the opinion for the Court, with a dissent from Justice Breyer. Monitor this space and www.JacksonLewis.com for detailed analysis of this decision in the days to come.